Clinical pharmacokinetics of rocuronium bromide

Clinical Pharmacokinetics

Volumn 31, Issue 3, 1996, Pages 174-183

  Khuenl Brady, Karin S ^a   Sparr, Harald ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM BROMIDE; PROPOFOL; ROCURONIUM; VECURONIUM;

AGE; CARDIOTOXICITY; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHERMIA; KIDNEY FAILURE; LIVER CIRRHOSIS; NEUROMUSCULAR BLOCKING; PHARMACODYNAMICS; PHARMACOKINETICS; PREGNANCY; PRIORITY JOURNAL; REVIEW;

EID: 0029815561     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199631030-00002     Document Type: Review

References (53)

1. Lambalk LM, DeWit APM, Wierda JMKH, et al. Dose-response relationship and time course of action of Org 9426. Anaesthesia 1991; 46: 907-11
2. Booij LHDJ, Knape HTA. The neuromuscular blocking effect of Org 9426. Anaesthesia 1991; 46: 341-3
3. Cooper RA, Mirakhur RK, Elliott P, et al. Estimation of the potency of Org 9426 using two different modes of nerve stimulation. Can J Anaesth 1992; 39: 139-42
4. Huizinga ACT, Vandenbrom RHG, Wierda JMKH, et al. Intubating conditions and onset of neuromuscular block of rocuronium (Org 9426); a comparison with suxamethonium. Acta Anaesthiol Scand 1992; 36: 463-8
5. Pühringer FK, Khuenl-Brady KS, Koller J, et al. Evaluation of the endotracheal intubating conditions of rocuronium (Org 9426) and succinylcholine in outpatient surgery. Anesth Analg 1992; 75: 37-40
6. Meistelman C, Plaud B, Donati F. Rocuronium (Org 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth 1992; 39: 665-9
7. 2-sufentanil anesthesia. Anesth Analg 1994; 78: 318-21
8. McCoy P, Maddineni VR, Elliott P, et al. Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium. Can J Anaesth 1993; 40: 703-8
9. Woelfel SK, Brandom BW, Cook DR, et al. Effects of bolus administration of ORG 9426 in children during nitrous oxide-halothane anesthesia. Anesthesiology 1992; 76: 939-42
10. Muir AW, Houston J, Green KL, et al. Effects of a new neuromuscular blocking agent (ORG 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 1989; 63: 400-10
11. Paanakker JE, Thio JMSL, Van den Wildenberg HM, et al. Assays of vecuronium in plasma using solid-phase extraction, HPLC and post-column ion-pair extraction with fluorimetric detection. J Chromatogr 1987; 421: 327-35
12. Kleef UW, Proost JH, Roggeveld J, et al. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. J Chromatogr 1993; 621: 63-76
13. Furuta F, Canfell PC, Castagnoli KP, et al. Quantification of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. J Chromatogr 1988; 427: 41-53
14. Press WH, Flannery BP, Teukolsky SA, et al., editors. Numerical recipes: the art of scientific computing. Cambridge: Cambridge University Press, 1986
15. Wagner JG. Fundamentals of clinical pharmacokinetics. Hamilton (III): Drug Intelligence Publications Inc., 1975
16. Wierda JMKH, Proost JH, Schiere S, et al. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans. Eur J Anaesthesiol 1994; 11 Suppl. 9: 66-74
17. Beal SL, Sheiner LB. NONMEM user's guide. San Francisco: University of California, 1979
18. Beal SL, Sheiner LB. Methodology of population pharmacokinetics. In: Garrett ER, Hirt J, editors. Drug fate and metabolism: methods and techniques. New York: Marcel Dekker, 1995: 135-83
19. Abouleish E, Abboud T, Lechevalier T, et al. Rocuronium (Org 9426) for Caesarean section. Br J Anaesth 1994; 73: 336-41
20. Segredo V, Mattey M, Sharma M, et al. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 1990; 72: 566-70
21. Van den Broek L, Wierda JMKH, Smeulers NJ, et al. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics. J Clin Anesth 1994; 6: 288-96
22. Alvarez-Gomez JA, Estelles ME, Fabregat J, et al. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients. Eur J Anaesthesiol 1994; 11 Suppl. 9: 53-6
23. Bencini AF, Seaf AHJ, Sohn YJ, et al. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or venal failure. Anesth Analg 1986; 65: 245-51
24. Wierda JMKH, Kleef UW, Lambalk LM, et al. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38: 430-5
25. Khuenl-Brady KS, Castagnoli KP, Canfell PC, et al. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology 1990; 72: 669-74
26. Bowman WC, Rodger IW, Houston J, et al. Structure: action relationship among some desacetoxy analogues of pancuronium and vecuronium in the cat. Anesthesiology 1988; 69: 57-62
27. Wierda JMKH, Proost JH, Muir AW, et al. Design of drugs for rapid onset. Anaesth Pharmacol Rev 1993; 1: 57-68
28. Wierda JMKH, Proost JH. The pharmacokinetics and the pharmacokinetic-dynamic relationship of rocuronium bromide. Anaesth Pharm Rev 1995; 3: 192-201
29. Plaud B, Proost JH, Wierda JMKH, et al. Pharmacokinetics and pharmacodynamies of rocuronium at the vocal cords and the adductor pollicis in humans. Clin Pharmacol Ther 1995; 58 (2): 185-91
30. Sohn YJ, Bencini AF, Scaf AHJ, et al. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients. Anesth Analg 1986; 65: 233-9
31. Sparr HJ, Khuenl-Brady KS, Eriksson LI. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia. Eur J Anaesthiol 1994; 11 Suppl. 9: 63-5
32. McCoy EP, Mirakhur RK, Maddineni VR, et al. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia. Br J Anaesth 1996; 76: 29-33
33. Larijani GE, Gratz I, Afshar M, et al. The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement. Pharmacotherapy 1995; 15: 36-41
34. 2O-halothane anesthesia. Anesthesiology 1992; 77: A907
35. Motsch J, Leuwer M, Pfau M, et al. Time course of action and recovery of rocuronium bromide in children during halothane anaesthesia - a preliminary report. Eur J Anaesthesiol 1994; 11 Suppl. 9: 75-7
36. Meretoja OA, Taivainen T, Erkola O, et al. Dose-response and time course of effect of rocuronium bromide in paediatric patterns. Eur J Anaesthesiol 1995; 12 Suppl. 11: 19-22
37. Vuksanaj D, Fisher DM. Pharmacokinetics of rocuronium in children aged 4-11 years. Anesthesiology 1995; 82: 1104-10
38. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993; 77: 1193-7
39. Bevan DR, Fisel P, Balendran P, et al. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 1993; 40: 127-32
40. Szenohradszky J, Fisher DM, Segredo V, et al. Pharmacokinetics of rocuronium bromide (Org 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992; 77: 899-904
41. Cooper RA, Maddineni VR, Mirakhur RK, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71: 222-6
42. Khuenl-Brady KS, Pomaroli A, Pühringer F, et al. The use of rocuronium (Org 9426) in patients wild chronic renal failure. Anaesthesia 1993; 48: 873-5
43. Khalil M, D'Honneur G, Duvaldestin P, et al. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994; 80: 1241-7
44. Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 1995; 80: 754-9
45. Boyd AH, van Miert MM, Eastwood NB, et al. Pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Anaesth 1994; 73: P262
46. Hunter JM. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis. Eur J Anaesth 1995; 12 Suppl. 11: 39-42
47. Dailey PA, Fisher DM, Shnider SM, et al. Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during Cesarean section. Anesthesiology 1984; 60: 599-605
48. Beaufort AM, Wierda JMKH, Belopavlonic M, et al. The influence of hypothermia (surface cooling) on the time course of action and on the pharmacokinetics of rocuronium in humans. Fur J Anaesthesiol 1995; 12 Suppl. 11: 95-106
49. Mol WEM, Fokkema GN, Ween B, et al. Mechanisms for the hepatic uptake of organic cations. Studies with the muscle relaxant vecuronium in isolated rat hepatocytes. J Pharmacol Exp Ther 1988; 244: 268-75
50. Miller RD, Agoston S, van der Pol F, et al. Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat. J Pharmacol Exp Ther 1978; 207: 532-8
51. Smeulers NJ, Wierda JMKH, Van den Brock L. et al. Hypothermic cardiopulmonary bypass influences, the concentration-response relationship and the biodisposition of rocuronium. Eur J Anaesthesiol 1995; 12 Suppl. 11: 91-4
52. Agoston S, Khuenl-Brady KS, Seyr M, et al. Use of neuromuscular blocking agents in the intensive care unit. In: Partridge B, Benumof JL, editors. Anesthesiology clinics of North America: advances in the use of muscle relaxants. Philadelphia: WB Saunders, 1993: 345-59
53. Khuenl-Brady KS, Sparr H, Pühringer F, et al. Rocuronium bromide in the ICU: dose finding and pharmacokinetics Eur J Anaesthesiol 1995; 12 Suppl. 11: 79-80